BIOCELTIX SPÓŁKA AKCYJNA
UL. BIERUTOWSKA 57-59 / BUD.III, 51-317 WROCŁAW
TAX ID8992794360
Rate company:
BIOCELTIX SPÓŁKA AKCYJNA
TAX ID8992794360
KRS0000744521
Share capital492,446.80 zł
address
UL. BIERUTOWSKA 57-59 / BUD.III, 51-317 WROCŁAW
Website
http://bioceltix.com/Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
8992794360 
REGON
364963245
KRS
0000744521
Legal form
joint stock company
Register Address
UL. BIERUTOWSKA 57-59 / BUD.III, 51-317 WROCŁAW
Date of registration in KRS
2018-08-13
Date of commencement of economic activity
2018-08-13
Act signature
WR.VI NS-REJ.KRS/22642/24/862
Website
HTTP://BIOCELTIX.COM/
Pkd codes
72.11.Z - Research and experimental development on biotechnology
10.91.Z - Manufacture of prepared feeds for farm animals
10.92.Z - Manufacture of prepared pet foods
20.20.Z - Manufacture of pesticides and other agrochemical products
20.42.Z - Manufacture of perfumes and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical substances
46.46.Z - Wholesale of pharmaceutical goods
46.75.Z - Wholesale of chemical products
72.19.Z - Other research and experimental development on natural sciences and engineering
Payer VAT status
Active
Vat list bank account(s)
PL94 1050 1575 1000 0090 8300 2296 
PL19 1050 1575 1000 0090 8300 2288 PL18 1050 1575 1000 0090 8300 6768 PL97 1050 1575 1000 0090 3295 4316 PL22 1050 1575 1000 0090 3295 4308 Show more bank accounts from VAT list (2)
EU grants
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2019 | 2020 | 2021 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | -1,6 | -2,4 | -4,4 | -79,2 |
EBITDA | -1,5 | -2,4 | -4 | -68 |
Short time liabilities | 0,6 | 0,5 | 0,9 | 81,1 |
Equity capital | 1,9 | 3,1 | 6 | 96,3 |
Operating profit (EBIT) | -1,6 | -2,4 | -4,3 | -77,3 |
Assets | 3,2 | 4,4 | 8,2 | 85,9 |
Net profit (loss) | -1,6 | -2,4 | -4,4 | -80,9 |
Cash | 1,1 | 3,2 | 6,1 | 89 |
Liabilities and provisions for liabilities | 1,3 | 1,4 | 2,2 | 62,3 |
Net income from sale | 0 | 0 | 0 | -100 |
Working assets | 1,7 | 3,4 | 6,5 | 90,2 |
Depreciation | 0 | 0,1 | 0,4 | 323,5 |
% | % | % | p.p. | |
Profitability of capital | -83,8 | -79,6 | -73,3 | 6,3 |
Equity capital to total assets | 59 | 69,3 | 73,2 | 3,9 |
Gross profit margin | -106 422,5 | -22 509,5 | 83 913 | |
EBITDA Margin | -101 800,9 | -21 840,2 | 79 960,7 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 137 606 | 16 669 | 2 147 483 648 | 2 147 466 979 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xhtml01-01-2023 - 31-12-2023
Activity report
Download xhtml01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download xhtml01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.